Leiters, an FDA-registered 503B outsourcing provider of high-quality ophthalmology and hospital-based services, announced recently that it is pleased to provide repackaged Avastin® in compliance with the Food and Drug Administration's 2018 final guidance for "Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application." Visit here to read the full press release.
To learn more about Leiters, visit www.leiters.com or click on "Learn More" below.
Your product information request has been received and we will forward information to the contact information you provided shortly.